Back to Directory

Justine Beck

Email

Justine.beck@nih.gov

Phone

301-761-5288

Institution

PAB, DAIDS, NIAID, NIH

Address

Pharmaceutical Affairs Branch
5601 Fishers Lane
MSC 9829
Rockville, MD 20852

Request an Update

Affiliated Studies

IMPAACT 2042: Tatelo Plus

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

IMPAACT 2039: EXCEED

DAIDS Number

Research Area

Cure and Immunotherapy

Study Status

IMPAACT 2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Delamanid in Combination with Optimized Multidrug Background Regimen (OBR) in Children with MDR-TB with and without HIV

DAIDS Number

Research Area

Study Status

IMPAACT 2014: Phase I/II Study of the Pharmacokinetics, Safety and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-infected Children and Adolescents

DAIDS Number

Research Area

Study Status

IMPAACT 2020: Phase II Study of Shortened Oral Treatment for Rifampicin-Resistant Tuberculosis in Children

DAIDS Number

Research Area

Study Status